Who is amplifying whom in the ASCO 2026 Annual Meeting GI-cancer conversation on X. Nodes are accounts; edges are retweets, quotes, and mentions. Node size scales with impressions; ring color marks account type. Use the GI Trial filter to isolate the sub-network behind any single trial.
← Back to the GI Attendee NetworkThis visualization is compiled by the KOL Pulse research team from curated GI-cancer tweets tagged to ASCO 2026 and enriched with engagement identities via the X API. Every account is classified against the KOL Pulse registry (verified US physicians are cross-referenced with CMS Open Payments). No accounts are fabricated; all tweet counts and impressions are as reported by X.
It maps the retweet, quote, and mention relationships among 1238 X/Twitter accounts discussing GI cancer research at ASCO 2026 Annual Meeting. Node size reflects impressions; ring color reflects account type (verified US physician, international MD, media/org, amplifier, or mentioned). 127 accounts authored original GI-cancer tweets.
Use the GI Trial dropdown in the left control panel. Selecting a trial (for example RASolute 302, EMERALD-3, HERIZON-GEA-01, BREAKWATER, or ATOMIC) shows only the accounts and edges tied to that trial. An account is tied to a trial when it authored a tweet tagged to that trial or engaged a KOL who did. Choose 'All GI trials' to return to the full network.
Accounts classified as US physicians are cross-referenced against the CMS Open Payments dataset and the KOL Pulse classified registry. They render with a gold ring and a US badge.
The filterable trials (each tied to at least three curated tweets) are RASolute 302, EMERALD-3, HERIZON-GEA-01, EMERALD-1, BREAKWATER, RMC-6236-001, STAR-221, CIRCULATE, ATTRACTION-6, SWOG S2107, ATOMIC, EPISODE III.
KOL Pulse curated 336 GI-cancer tweets tagged to ASCO 2026 and enriched them with engagement identities (who retweeted and quoted each post) via the X API. Accounts were then classified using the KOL Pulse registry.